Navigation Links
LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results
Date:9/29/2009

SAN DIEGO, Sept. 29 /PRNewswire-FirstCall/ -- LifeVantage Corporation (OTC Bulletin Board: LFVN), a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based solutions for oxidative stress and the maker of both Protandim® and TrueScience(TM) Anti-Aging Cream, announced today fourth quarter and fiscal year 2009 financial and operating results.

The Company recorded net revenues of $4.1 million and a net loss of ($9.1) million, or ($0.23) per share, for its year ended June 30, 2009. For its year ended June 30, 2008, the Company recorded net revenues of $3.2 million and a net loss of ($2.1) million or ($0.09) per share.

During its fourth quarter fiscal year 2009, the Company recorded net revenue of $1.6 million, which represents an increase of approximately 150% from the net revenue of $0.6 million for the third quarter fiscal year 2009 and a net loss of ($5.3) million or ($0.11) per share. During its fourth quarter fiscal year 2008, the Company recorded net revenues of $0.8 million and a net loss of $(0.7) million, or $(0.03) per share.

"This past fiscal year has been a transitional one for LifeVantage," stated David W. Brown, President & CEO. "We entered the multi-billion dollar network marketing industry, by far the fastest growing sales channel for dietary supplements, and we believe, the best avenue for marketing the Company's products. Furthermore, we announced a unique 'inside-out' approach to anti-aging with the launch of our second product, TrueScience Anti-Aging Cream. On the inside of the body, Protandim, our flagship nutritional supplement, has been clinically proven to reduce the rate of cellular aging. Offering a unique, effective skin care product to address the skin, or the 'outside,' was a logical extension of our Protandim product line. Continuing
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. DOR BioPharma Announces Private Equity Financing of $3.85 Million with its Partner Sigma-Tau and Other Institutional Investors
2. Mardil, Inc. Announces Positive Preliminary Results of Pilot Study With BACE(TM) Device at Annual TCT Conference
3. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial
4. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
5. Pres. Clinton Announces Commitment From Inter-American Development Bank, Global Network for Neglected Tropical Diseases, and Pan American Health Organization to Mobilize $30 Million to Fight NTDs in the Americas at CGI Conference
6. Sangamo BioSciences Announces Plans to Initiate a Second Clinical Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
7. Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Tests Impact on Weight Loss
8. Medivation Announces Initiation of Phase 3 Clinical Trial of MDV3100 in Advanced Prostate Cancer
9. Bayer Announces New Data on Oncology Portfolio To Be Presented at the ECCO-ESMO Congress 2009
10. Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
11. Enobia Announces Positive Clinical Results With ENB-0040, a Bone Targeted Enzyme Replacement Therapy for Hypophosphatasia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015  Fair Rate Funding, a leader in TV ... Delaware found Thursday that Boston ... pelvic organ prolapse (POP) and Stress Urinary Incontinence (SUI) ... hid the design flaws from the plaintiff, Deborah ... Transvaginal mesh, also known as TV ...
(Date:5/29/2015)... May 29, 2015  Dr. Yair Walzer has ... vaginal health issues often caused by menopause. The MonaLisa Touch™, ... anesthesia, received FDA clearance in 2014. Dr. Walzer is one ... to offer the special fractional CO 2 laser specifically ... survivors. In 2010 there were greater than ...
(Date:5/29/2015)... Massachusetts and SPARTANBURG, South Carolina ... The Guardian Research Network and Molecular Health have announced ... and molecular diagnostic decision support to the majority of ... Guardian Research Network will collaborate with Molecular Health to ... testing to identify cohorts from hundreds of thousands of ...
Breaking Medicine Technology:TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 2TV Mesh Lawsuit Funding Firm, Fair Rate Funding, Reports Delaware Woman Awarded $100 Million Against Boston Scientific in Pelvic Mesh Verdict. 3The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 2New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 3New Collaboration to Dramatically Expand Therapeutic Clinical Trial Access for Cancer Patients Across the United States 4
... Conatus Pharmaceuticals Inc. today announced the closing of ... financing.  This financing was led by new investor, AgeChem ... existing investors; Aberdare Ventures, Advent Venture Partners, Bay City ... will use the proceeds to advance the clinical development ...
... Mindray Medical International Limited (NYSE: MR), a leading developer, ... that it will report its financial results for the ... market closes on February 28, 2011. Mindray,s management will ... March 1, 2011 U.S. Eastern Time (9:00 PM on ...
Cached Medicine Technology:Conatus Pharmaceuticals Completes $20 Million Series B Private Placement Financing 2Mindray to Report Fourth Quarter and Full Year 2010 Financial Results on February 28, 2011 2
(Date:5/29/2015)... Washington, PA (PRWEB) May 29, 2015 ... ” quiz-based learning in 14 medical specialties, now offers ... includes a wide spectrum of rheumatology disorders ranging from ... Alfred Saint Jacques, editorial director of MDLinx, and Caroline ... excited about the impact it will have on the ...
(Date:5/29/2015)... May 29, 2015 The Recovery ... substance abuse, and co-occurring mental health treatment facility, ... cutting for the general public on June 1st, ... The Recovery Village at Palmer Lake will offer ... programming, utilizing traditional and evidence-based therapies, in a ...
(Date:5/29/2015)... On May 21, 2015, Elle Magazine in article titled ... Botox ?” reported on the four most commonly searched beauty ... to determine these results and then sought expert help to ... example, is how to keep neck skin tight . ... the appropriate age to start receiving Botox injections . ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Johnson ... reached a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) ... gynecomastia due to his use of the antipsychotic ... been selected for the third bellwether trial to ... tort litigation underway in Pennsylvania’s Philadelphia Court of ...
(Date:5/29/2015)... 2015 Intermountain Healthcare of ... Stratus Video Interpreting for on-demand ... communication and timely care for patients with ... Stratus’ video remote interpreting (VRI) services will ... to quickly access qualified medical interpretation in ...
Breaking Medicine News(10 mins):Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Advanced Recovery Systems Announces the Opening of The Recovery Village at Palmer Lake 2Health News:Botox, Wrinkles and Double Chins: The Most-Asked Beauty Problems According to Google 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 2Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 3Health News:Stratus Video Interpreting Partners With Intermountain Healthcare to Provide On-Demand Interpretation Services for Patients With Limited English Proficiency (LEP) 4
... National ... Immunization Awareness Month, NORTH HAVEN, Conn., Sept. 6 In ... in,Connecticut is reminding parents to make sure their adolescents,immunizations are up ... the perfect time for parents to check with their child,s provider,to ...
... Hospital Directory show new rules issued by the Centers, for ... rural hospitals and hospitals specializing in cardiac care. ... changes in outlier payment are also forecasted., ... Services (CMS) has issued the most sweeping rule,changes for hospital ...
... IV product a proven treatment -, BELLEVILLE, ... (TSX: BNC), a research-based, technology-driven Canadian,biopharmaceutical company, today ... to Australia in order to be able to ... that continent,s equine influenza outbreak.,The outbreak began in ...
... of women with breast cancer stopped taking a commonly ... to a new study from researchers at the University ... the study were taking aromatase inhibitors, a type of ... fuels some breast cancers. The treatment is generally given ...
... LOUISVILLE, Ky., Sept. 5 Ventas, Inc. (NYSE:,VTR) ("Ventas" ... Directors,declared a regular quarterly dividend of $0.475 per share, ... record on September 17, 2007. The,dividend is the third ... dividend. Ventas, Inc. is a leading healthcare real ...
... a,wholly owned subsidiary of Siemens Corporation, announced today that ... offer for all outstanding,shares of common stock of Dade ... has been extended to 12:00 Midnight, New York City ... being made pursuant to,an Agreement and Plan of Merger, ...
Cached Medicine News:Health News:Immunizations Part of Back to School Preparations 2Health News:Immunizations Part of Back to School Preparations 3Health News:Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations 2Health News:Bioniche Responds to Australian Equine Influenza Outbreak 2Health News:Bioniche Responds to Australian Equine Influenza Outbreak 3Health News:13 percent of women stop taking breast cancer drug because of side effects, U-M study finds 2Health News:13 percent of women stop taking breast cancer drug because of side effects, U-M study finds 3Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 2Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 3Health News:Ventas Declares Regular Quarterly Dividend of $0.475 Per Share 4Health News:Siemens Extends Tender Offer for Acquisition of Dade Behring 2
... patented Miami J® collar is designed to ... patient. Break-through fabrics inhibit decubitus during long-term ... and speed recovery. And the unique ... any prefabricated extended wear collar. And kids ...
One-piece rigid cervical collar is designed to fit securely around the neck and mandible to provide immobilization and support of the cervical region...
Model C-10 is a four post cervical orthosis which controls flexion, extension, lateral flexion, rotation, and axial motion. Each post may be individually adjusted in height....
... Orthosis ensures comfort and immobilization ... anterior frame and occipital component. ... flow and easy application. Large ... For added comfort, removable, flannel-covered, ...
Medicine Products: